News & Perspective

Sep 19, 2006

Sep 19, 2006

Sanofi tests H7N1 flu vaccine for pandemic readiness

(CIDRAP News) – Sanofi Pasteur today announced the start of the first clinical trial of an H7N1 influenza vaccine, intended to guard against the threat of a pandemic caused by H7 strains of avian influenza.

Current concern about a flu pandemic focuses mainly on the H5N1 avian flu virus, which has infected at least 247 people and killed 144. But H7 avian flu viruses have caused a number of mild illness cases and one death in the past 3 years.

Jul 18, 2006

Jul 18, 2006

Novartis to build US cell-based flu vaccine plant

(CIDRAP News) – Novartis, the Swiss-based drug manufacturer, today announced plans to build what it says will be the first US plant to make cell-culture-based influenza vaccines.

The facility will be built in Holly Springs, N.C., at a total cost of about $600 million, the company said in a news release. It will be able to produce about 50 million doses of seasonal trivalent (three-strain) flu vaccine annually.

Jun 28, 2006

Jun 28, 2006

Report: Flu pandemic could cut economic output 3-9%

(CIDRAP News) – An influenza pandemic would reduce the gross domestic products of the world's major economies by amounts ranging from 9% in China to 3% in Canada, according to a recent report by the Australian Bureau of Agricultural and Resource Economics (ABARE).

Jun 09, 2006

Jun 09, 2006

Officials call Asia-Pacific pandemic drill a success

(CIDRAP News) – Australian officials who coordinated an exercise Jun 7 and 8 on pandemic influenza response among Asia-Pacific nations called the drill a success, according to an Agence France-Presse (AFP) story today.

Apr 24, 2006

Apr 24, 2006

Study cites gaps in Europe's flu pandemic plans

(CIDRAP News) – European countries' plans for coping with an influenza pandemic are generally good but have a number of gaps, including a lack of detail on distribution of drugs and supplies, according to an analysis published last week by The Lancet.

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»